SMIMM1131U Drug Discovery
Please note that this is the course description for the study year 2015/16. Information on course dates, prices etc. in coming semesters please visit www.mind.ku.dk
Master's Programme in Industrial Drug Development -
compulsory
Compulsory for Master of Industrial Drug Development (MIND)
students, elective for other part-time master's students at the
Faculty of Health and Medical Sciences (subject to study board
approval) and open for freelance students who meet the admission
criteria.
The course is intended for drug discovery and development
professionals who would like to incease their knowledge regarding
modern techniques used in target identification and validation, and
lead optimisation.
The following topics will be covered in lectures during the course:
- Target classes: receptors, channels, transporters and enzymes
- Target identification using bioinformatics, genetics and reverse pharmacology
- Target evaluation using bioinformatics
- Target validation using gene knock-down, knock-out and knock-in technologies
- Drug design aspects related to small molecules and biologics
- Pitfalls in drug discovery and translational aspects going from a molecular target to whole animals
- Case stories
Target prioritization, bioinformatics and literature searching will be covered in workshops.
The overall objective of the course is to provide the student
with a general comprehension of the elements involved in modern
drug discovery. Today, almost all drug discovery programs are
directed towards design of either small molecules or biologics
acting selectively at specific targets. As an initial step, the
target involved in a given disease has to be identified and
validated, which will subsequently lead to design of ligands acting
selectively in a desired fashion at the target. During this lead
optimization process a growing number of considerations, besides
the action at the disease target, have to be taken into
consideration such as ADME, toxicology and production issues.
Finally, the lead candidates have to show efficacy in relevant
animal disease models before the final candidate can enter
pre-clinical studies. In the current course we will focus on the
target identification and validation as well as the lead
optimization processes.
Upon completion of the course, participants are expected to be able
to:
Knowledge
- Demonstrate comprehension of target identification and validation methods and processes
- Demonstrate insight into lead optimization methods and processes
Skills
- Apply basic computational methods in the area of bioinformatics
- Ability to select important parameters for lead optimization and lead candidate progression
- Orally present a subject in the drug discovery area (however, this is not part of the assessment)
Competencies
- Conduct a valid scientific literature study in the area of drug discovery
- Write a scientifically based report on drug discovery aspects using scientific literature
A basic knowledge of gene transcription & translation and the drug discovery process is required, which can be obtained by reading chapter 1 from "Analysis of Genes and Genomes" by Richard J. Reece (Wiley, ISBN 0470777826) and chapter 4 from “Drug Discovery and Development" by Humphrey P. Rang (Churchill Livingstone, ISBN 0443064202), respectively. In addition chapter 5 and 6 of the latter book is required reading for the workshop on the first day. Additional chapters of both books cover many of the subjects of the course and are thus recommended reading (a list of recommended reading will be provided before the course). The examination report will be based on a literature search performed by the participants and there is therefore no common syllabus for the course. A couple of reviews will be provided by the organizers prior to the course as an introduction to the examination topic.
• A relevant bachelor degree or equivalent
• A minimum of 2 years of relevant job experience
• Proficiency in English
- Category
- Hours
- Exam
- 20
- Lectures
- 20
- Preparation
- 22
- Theory exercises
- 20
- Total
- 82
1 December 2015.
Apply
here
- Credit
- 3 ECTS
- Type of assessment
- Written assignmentThe individual written assignment is based on a case story. The assignment must be based on original peer-reviewed scientific articles found by literature search performed by the participants and there is therefore no common syllabus for the course. The participants will be introduced to literature searches during the course and the examination assignment is typically based on 20-40 articles.
- Marking scale
- 7-point grading scale
- Censorship form
- External censorship
- Exam period
Deadline for submission of written report: 12 April 2016 at 4 PM.
- Re-exam
13 May 2016
Criteria for exam assesment
The grade 12 is given when the participant:
- writes a report in his/hers own words, which demonstrates an exhaustive literature search and the most important literature relevant for the selected case has been properly referenced
- demonstrates an ability to analyze, recapitulate and critically evaluate the most important literature for the selected case
- demonstrates a correct use of the terms used in the field of drug discovery
- demonstrates that he/she masters the central concepts in the field of drug discovery and has an ability to combine the disciplines with each other in the analysis of the selected case
- writes a coherent report, which within the size limit provides an excellent balance of the various sub-topics of the selected case
The grade 7 is given when the participant:
- writes a report in his/hers own words, which demonstrates a throughout literature search and important literature relevant for the selected case has been properly referenced
- demonstrates an ability to analyze and recapitulate relevant literature for the selected case
- demonstrates a fairly correct use of the terms used in the field of drug discovery
- demonstrates that he/she masters the central concepts in the field of drug discovery and has an understanding of the disciplines relevant for the selected case
- writes a coherent report, which within the size limit provides a proper balance of the various sub-topics of the selected case
The grade 02 is given when the participant:
- writes a report in his/hers own words, which demonstrates an satisfactory literature search and some important literature relevant for the selected case has been referenced
- demonstrates an ability to understand and report relevant literature for the selected case
- demonstrates knowledge of the terms used in the field of drug discovery
- demonstrates an understanding of the central concepts and disciplines relevant for the selected case
Course information
- Language
- English
- Course code
- SMIMM1131U
- Credit
- 3 ECTS
- Level
- Part Time Master
- Duration
- Placement
- Spring
7-11 March 2016.
- Schedule
- .
- Course capacity
- 25 participants
- Continuing and further education
- Price
DKK 12,900 (students from non-EU/EEA countries DKK 15.130). Fee includes course materials and meals. Prices may be subject to change. Textbook must be purchased by the participants.
- Study board
- Study Board for Part-time Master’s Programmes of Pharmaceutical Sciences
Contracting department
- Department of Drug Design and Pharmacology
Course responsibles
- Rasmus Prætorius Clausen (rac@sund.ku.dk)
- Stephan Pless (stephan.pless@sund.ku.dk)
Lecturers
The list of lecturers may be subject to change.
Peter Høngaard Andersen, H. Lundbeck
Hans Bräuner-Osborne, University of Copenhagen
Harald S. Hansen, University of Copenhagen
Rasmus P. Clausen, University of Copenhagen
Lotte Bjerre Knudsen, Novo Nordisk
Troels Koch, Santaris
Ulrik Svane Sørensen, NeuroSearch
Cord Brakebusch, BRIC/University of Copenhagen
Søren-Peter Olesen, University of Copenhagen
David Gloriam, University of Copenhagen
Klaus Bøgesø, H. Lundbeck
Torben Hansen, University of Copenhagen
Kristian Strømgaard, University of Copenhagen
Niels Plath, H. Lundbeck
Thomas Høeg-Jensen, Novo Nordisk
Stephan Cristgau, Novo Seeds